307 related articles for article (PubMed ID: 27595546)
41. Functional interactions of Prp8 with both splice sites at the spliceosomal catalytic center.
Siatecka M; Reyes JL; Konarska MM
Genes Dev; 1999 Aug; 13(15):1983-93. PubMed ID: 10444596
[TBL] [Abstract][Full Text] [Related]
42. Determination of the RNA binding specificity of the heterogeneous nuclear ribonucleoprotein (hnRNP) H/H'/F/2H9 family.
Caputi M; Zahler AM
J Biol Chem; 2001 Nov; 276(47):43850-9. PubMed ID: 11571276
[TBL] [Abstract][Full Text] [Related]
43. Aberrant 5' splice sites in human disease genes: mutation pattern, nucleotide structure and comparison of computational tools that predict their utilization.
Buratti E; Chivers M; Královicová J; Romano M; Baralle M; Krainer AR; Vorechovsky I
Nucleic Acids Res; 2007; 35(13):4250-63. PubMed ID: 17576681
[TBL] [Abstract][Full Text] [Related]
44. hnRNP H binding at the 5' splice site correlates with the pathological effect of two intronic mutations in the NF-1 and TSHbeta genes.
Buratti E; Baralle M; De Conti L; Baralle D; Romano M; Ayala YM; Baralle FE
Nucleic Acids Res; 2004; 32(14):4224-36. PubMed ID: 15299088
[TBL] [Abstract][Full Text] [Related]
45. Systematic identification and analysis of exonic splicing silencers.
Wang Z; Rolish ME; Yeo G; Tung V; Mawson M; Burge CB
Cell; 2004 Dec; 119(6):831-45. PubMed ID: 15607979
[TBL] [Abstract][Full Text] [Related]
46. Modeling splicing outcome by combining 5'ss strength and splicing regulatory elements.
Müller L; Ptok J; Nisar A; Antemann J; Grothmann R; Hillebrand F; Brillen AL; Ritchie A; Theiss S; Schaal H
Nucleic Acids Res; 2022 Aug; 50(15):8834-8851. PubMed ID: 35947702
[TBL] [Abstract][Full Text] [Related]
47. Pseudoexon activation in disease by non-splice site deep intronic sequence variation - wild type pseudoexons constitute high-risk sites in the human genome.
Petersen USS; Doktor TK; Andresen BS
Hum Mutat; 2022 Feb; 43(2):103-127. PubMed ID: 34837434
[TBL] [Abstract][Full Text] [Related]
48. A second exon splicing silencer within human immunodeficiency virus type 1 tat exon 2 represses splicing of Tat mRNA and binds protein hnRNP H.
Jacquenet S; Méreau A; Bilodeau PS; Damier L; Stoltzfus CM; Branlant C
J Biol Chem; 2001 Nov; 276(44):40464-75. PubMed ID: 11526107
[TBL] [Abstract][Full Text] [Related]
49. A Janus splicing regulatory element modulates HIV-1 tat and rev mRNA production by coordination of hnRNP A1 cooperative binding.
Marchand V; Méreau A; Jacquenet S; Thomas D; Mougin A; Gattoni R; Stévenin J; Branlant C
J Mol Biol; 2002 Nov; 323(4):629-52. PubMed ID: 12419255
[TBL] [Abstract][Full Text] [Related]
50. Solution Structure of the HIV-1 Intron Splicing Silencer and Its Interactions with the UP1 Domain of Heterogeneous Nuclear Ribonucleoprotein (hnRNP) A1.
Jain N; Morgan CE; Rife BD; Salemi M; Tolbert BS
J Biol Chem; 2016 Jan; 291(5):2331-44. PubMed ID: 26607354
[TBL] [Abstract][Full Text] [Related]
51. Unbalanced GLA mRNAs ratio quantified by real-time PCR in Fabry patients' fibroblasts results in Fabry disease.
Filoni C; Caciotti A; Carraresi L; Donati MA; Mignani R; Parini R; Filocamo M; Soliani F; Simi L; Guerrini R; Zammarchi E; Morrone A
Eur J Hum Genet; 2008 Nov; 16(11):1311-7. PubMed ID: 18560446
[TBL] [Abstract][Full Text] [Related]
52. hnRNP A1 contacts exon 5 to promote exon 6 inclusion of apoptotic Fas gene.
Oh Hk; Lee E; Jang HN; Lee J; Moon H; Sheng Z; Jun Y; Loh TJ; Cho S; Zhou J; Green MR; Zheng X; Shen H
Apoptosis; 2013 Jul; 18(7):825-35. PubMed ID: 23430061
[TBL] [Abstract][Full Text] [Related]
53. Distinct sets of adjacent heterogeneous nuclear ribonucleoprotein (hnRNP) A1/A2 binding sites control 5' splice site selection in the hnRNP A1 mRNA precursor.
Hutchison S; LeBel C; Blanchette M; Chabot B
J Biol Chem; 2002 Aug; 277(33):29745-52. PubMed ID: 12060656
[TBL] [Abstract][Full Text] [Related]
54. Extensive in silico analysis of NF1 splicing defects uncovers determinants for splicing outcome upon 5' splice-site disruption.
Wimmer K; Roca X; Beiglböck H; Callens T; Etzler J; Rao AR; Krainer AR; Fonatsch C; Messiaen L
Hum Mutat; 2007 Jun; 28(6):599-612. PubMed ID: 17311297
[TBL] [Abstract][Full Text] [Related]
55. Control of HIV-1 env RNA splicing and transport: investigating the role of hnRNP A1 in exon splicing silencer (ESS3a) function.
Asai K; Platt C; Cochrane A
Virology; 2003 Sep; 314(1):229-42. PubMed ID: 14517076
[TBL] [Abstract][Full Text] [Related]
56. hnRNP L and hnRNP A1 induce extended U1 snRNA interactions with an exon to repress spliceosome assembly.
Chiou NT; Shankarling G; Lynch KW
Mol Cell; 2013 Mar; 49(5):972-82. PubMed ID: 23394998
[TBL] [Abstract][Full Text] [Related]
57. Identification of an hnRNP A1-dependent splicing silencer in the human papillomavirus type 16 L1 coding region that prevents premature expression of the late L1 gene.
Zhao X; Rush M; Schwartz S
J Virol; 2004 Oct; 78(20):10888-905. PubMed ID: 15452209
[TBL] [Abstract][Full Text] [Related]
58. Heterogeneous nuclear ribonucleoprotein H is required for optimal U11 small nuclear ribonucleoprotein binding to a retroviral RNA-processing control element: implications for U12-dependent RNA splicing.
McNally LM; Yee L; McNally MT
J Biol Chem; 2006 Feb; 281(5):2478-88. PubMed ID: 16308319
[TBL] [Abstract][Full Text] [Related]
59. Detailed molecular characterization of a novel IDS exonic mutation associated with multiple pseudoexon activation.
Grodecká L; Kováčová T; Kramárek M; Seneca S; Stouffs K; De Laet C; Majer F; Kršjaková T; Hujová P; Hrnčířová K; Souček P; Lissens W; Buratti E; Freiberger T
J Mol Med (Berl); 2017 Mar; 95(3):299-309. PubMed ID: 27837218
[TBL] [Abstract][Full Text] [Related]
60. Antisense Oligonucleotide Rescue of Deep-Intronic Variants Activating Pseudoexons in the 6-Pyruvoyl-Tetrahydropterin Synthase Gene.
Martínez-Pizarro A; Leal F; Holm LL; Doktor TK; Petersen USS; Bueno M; Thöny B; Pérez B; Andresen BS; Desviat LR
Nucleic Acid Ther; 2022 Oct; 32(5):378-390. PubMed ID: 35833796
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
